Latest Manufacturing Investment News

Waterco Limited (ASX:WAT) delivered record FY26 EBIT of $23.8 million and lifted net profit after tax 59.6% to $15.4 million, despite only modest revenue growth. The stronger result supports a higher fully franked dividend, but the group is carrying more debt and inventory as it expands manufacturing capacity.

Orthocell posts record FY26 revenue growth driven by expanding US and international sales of its collagen medical devices, while investing ahead in manufacturing capacity and product pipeline.

Adrad Holdings delivered a 15% rise in net profit after tax for FY26, driven by operational efficiency and growth in engineered heat transfer solutions, alongside a 15% dividend increase.

The Calmer Co. has signed a binding heads of agreement with Kaiming Agro Processing to establish a long-term manufacturing partnership, leveraging advanced extraction technology in Fiji to scale its premium botanical ingredients business globally.

Metals Australia has reported maiden ore reserves and strong economic studies for its Lac Carheil Graphite Project in Quebec, with a combined after-tax NPV of AUD 2.56 billion, positioning the company for a strategic revaluation as it advances feasibility studies.

Generation Development Group (ASX: GDG) closed FY26 with a 36% jump in funds under management to $46.4 billion, powered by record sales at Generation Life and a landmark strategic partnership with Colonial First State.

dorsaVi has moved from design to silicon manufacturing with the tape-out of its first 22-nm RRAM-CMOS validation chip, aiming to prove its advanced memory platform for AI and robotics applications.

Metals Australia’s prefeasibility study for its Lac Carheil Graphite Project in Quebec reveals a strong economic foundation with a pre-tax NPV of AUD 790.8 million and a 22% IRR, underpinning its potential as a significant future graphite supplier.

SDI Limited's acquisition by Beijing Guoci's subsidiary advances with ASIC registration of the scheme booklet and court approval to convene a shareholder meeting. The all-cash offer at a 53–58% premium awaits shareholder and final court approval.

Anteris Technologies reported a $22.9 million net loss in Q1 2026 but bolstered its cash position to $283 million following a $320 million capital raise. The company is scaling manufacturing and clinical activities for its DurAVR transcatheter heart valve, with US patient enrolment now underway in the pivotal PARADIGM Trial.

Green Technology Metals (ASX: GT1) secures A$11 million to complete feasibility studies and permitting for its Seymour Lithium Project, aiming for first ore in 2028 amid a recovering lithium market and strong Canadian support.

Metals Australia’s new PEA for its Quebec Battery Anode Material Refinery reveals robust economics with a $2.05 billion USD pre-tax NPV and a 25.6% IRR, underpinning plans for a final feasibility study.